MedPath

Comparison of therapeutic results of letrozole, tamoxifen, estradiol and vitamin E regimen with letrozole, tamoxifen and estradiol regimen in stimulating ovulation in infertile women with polycystic ovary syndrome: a double-blind randomized clinical trial study

Phase 2
Conditions
Polycystic ovary syndrome.
Registration Number
IRCT20150407021653N20
Lead Sponsor
Jahrom University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
90
Inclusion Criteria

Female gender
Infertile who have not had a history of pregnancy after 12 months of unprotected intercourse
Suffering from polycystic ovary syndrome
At least 40 years old

Exclusion Criteria

Non-consent to participate in the study
drug sensitivity to letrozole or tamoxifen or estradiol or vitamin E
the existence of any other pathology that has led to infertility in the patient or his wife
liver or kidney dysfunction
diabetes mellitus type one or two
Thyroid disordes
congenital adrenal hyperplasia
abnormal hysterosalpingography

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath